SOLENO THERAPEUTICS INC

Soleno Therapeutics Inc.

Biotechnology • Healthcare • Redwood City, CA, United States • SLNO (NCM)

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.

Stock Performance (90 Days)

Data through Dec 24, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Is Soleno Therapeutics, Inc. (SLNO) The Cheap Healthcare Stock To Buy Heading Into 2026? - Yahoo Finance
Yahoo Finance • Dec 10
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO - PR Newswire
PR Newswire • Jan 1
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
MarketBeat • Dec 31
Soleno Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors (SLNO) - Business Wire
Business Wire • Dec 31
Soleno Therapeutics stock slides today: SLNO drops on investor-alert headline as biotech sector slips - ts2.tech
ts2.tech • Dec 30

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has SOLENO THERAPEUTICS INC had layoffs?
No layoff events have been recorded for SOLENO THERAPEUTICS INC in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does SOLENO THERAPEUTICS INC have?
SOLENO THERAPEUTICS INC has approximately 152 employees.
What industry is SOLENO THERAPEUTICS INC in?
SOLENO THERAPEUTICS INC operates in the Biotechnology industry, within the Healthcare sector.
Is SOLENO THERAPEUTICS INC a publicly traded company?
Yes, SOLENO THERAPEUTICS INC is publicly traded under the ticker symbol SLNO on the NCM. The company has a market capitalization of approximately $2.64 billion.
Where is SOLENO THERAPEUTICS INC headquartered?
SOLENO THERAPEUTICS INC is headquartered in Redwood City, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.